Skip to main content
Clinical Trials/NCT02207855
NCT02207855CompletedNot Applicable

Chloroprocaine for Continuous Epidural Analgesia in Neonates and Infants

Joseph D. Tobias1 site in 1 country21 target enrollmentStarted: June 2014Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
21
Locations
1
Primary Endpoint
Pain score

Study Overview

Brief Summary

This a study to retrospectively review our experience with the use of chloroprocaine for postoperative epidural infusions in neonates and infants. Pain scores and the need for intravenous analgesic agents will be recorded from the records to demonstrate the efficacy of the technique.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Eligibility Criteria

Ages
— to 2 Years (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Neonates and infants who have received chloroprocaine for epidural anesthesia.

Exclusion Criteria

  • Not provided

Arms & Interventions

Chloroprocaine

Neonates and infants who have received chloroprocaine for epidural anesthesia.

Intervention: Chloroprocaine (Drug)

Outcomes

Primary Outcomes

Pain score

Time Frame: Every 6 hours for 72 hours

Secondary Outcomes

  • Pain medicine consumption(Every 6 hours for 72 hours)

Investigators

Sponsor
Joseph D. Tobias
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Joseph D. Tobias

Chairman, Dept. of Anesthesiology & Pain Medicine

Nationwide Children's Hospital

Study Sites (1)

Loading locations...

Similar Trials